According to BioMarin Pharmaceutical's latest financial reports the company's total assets are $6.84 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $6.84 B | 7.32% |
2022-12-31 | $6.37 B | 6.17% |
2021-12-31 | $6.00 B | 2.68% |
2020-12-31 | $5.84 B | 24.69% |
2019-12-31 | $4.69 B | 5.94% |
2018-12-31 | $4.42 B | -4.45% |
2017-12-31 | $4.63 B | 15.15% |
2016-12-31 | $4.02 B | 7.89% |
2015-12-31 | $3.72 B | 50.66% |
2014-12-31 | $2.47 B | 10.31% |
2013-12-31 | $2.24 B | 43.08% |
2012-12-31 | $1.56 B | 20.11% |
2011-12-31 | $1.30 B | 3.41% |
2010-12-31 | $1.26 B | 37.67% |
2009-12-31 | $0.91 B | 1.15% |
2008-12-31 | $0.90 B | 11.21% |
2007-12-31 | $0.81 B | 75.92% |
2006-12-31 | $0.46 B | 137.29% |
2005-12-31 | $0.19 B | -16.17% |
2004-12-31 | $0.23 B | -9.12% |
2003-12-31 | $0.25 B | 131.74% |
2002-12-31 | $0.11 B | -35.62% |
2001-12-31 | $0.17 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Sanofi SNY | $139.81 B | 1,943.62% | ๐ซ๐ท France |
Ultragenyx RARE | $1.49 B | -78.21% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $0.16 B | -97.58% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | $0.20 B | -96.99% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $0.77 B | -88.63% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $0.47 B | -93.13% | ๐บ๐ธ USA |